a UBE2A-related X-linked intellectual disability is characterized by a distinctive facial phenotype (dense eyebrows and eyelashes, synophrys, hypertelorism, upslanted palpebral fissures, wide mouth, and thin lips), generalized hirsutism, hypoplastic genitalia, short stature, hypotonia, seizures, and severe intellectual disability. Five affected males in two families are described here and compared with the previously reported 17 males in eight families. The new cases are notable for the absence of nail dystrophy, previously considered a defining manifestation, and for the presence of hypogammaglobulinemia and adultonset ataxia. Clin Dysmorphol 28:1-6
Introduction
Distinctive or unique growth, craniofacial features, malformations, neurological manifestations, sexual maturation, cutaneous findings, or other characteristics are usually required for the clinical recognition of a syndrome. Among the 183 X-linked intellectual disability (XLID) syndromes, less than half have such distinctive or unique patterns of clinical findings. Prominent among these are Aarskog, Aicardi, ATR-X, Börjeson-ForssmanLehmann, Fragile X, Incontinentia Pigmenti, Hunter, Rett, XLID-cleft lip/palate, and hydrocephaly-MASA syndromes. Most XLID syndromes require imaging, biochemical, or molecular studies before diagnosis.
UBE2A-related XLID (AKA XLID-nail dystrophyseizures, UBE2A deficiency syndrome, XLID syndrome type Nascimento: OMIM #300860) has facial, cutaneous, genital, and neurological manifestations that should allow recognition in the clinic. The face is characterized by thickened eyebrows and eyelashes, synophrys, hypertelorism, upslanted palpebral fissures, depressed nasal root, a wide mouth, thin lips, a short broad neck, and low nuchal hairline. In addition to generalized hirsutism, the cutaneous findings include dry thin and nail dystrophy. The penis is small. Developmental delay, intellectual disability, abnormal behaviors, seizures, hypotonia, and short stature add to the clinical presentation, but are not specific to UBE2A-related XLID.
Since the report by Nascimento et al. (2006) , seven additional families with UBE2A sequence variants have been identified (Nascimento et al., 2006; Budny et al., 2010; Czeschik et al., 2013; Tzschach et al., 2015; Tsurusaki et al., 2017; Giugliano et al., 2018) . Other males with deletions of UBE2A as a part of contiguous gene deletions and more complex phenotypes have been reported (De Leeuw et al., 2010; Honda et al., 2010; Czeschik et al., 2013; Utine et al., 2014; Thunstrom et al., 2015) . Two additional kindreds with UBE2A mutations including one reported before the 2006 report of Nascimento et al. (2006) as XLID-seizures-hypogammaglobulinemia--gait disturbance and assigned OMIM %300861 (X-linked mental retardation, Chudley-Schwartz type) are added with this report.
Clinical reports
A summary of the clinical findings in the five cases described here and the 17 previously reported cases is shown in Table 1 . Additional details on kindreds 8905 and 8435 are provided below.
K8905
Two affected brothers, a nonaffected carrier mother, and a noncarrier sister comprise the first kindred (Fig. 1a) . The mother experienced two pregnancy losses, the first of the fetuses having anencephaly.
III.2 was born at 41 weeks with normal growth parameters (weight 3544 g, length 50.8 cm, head circumference 33.5 cm). He developed hypoglycemia and myoclonic seizures on the first day of life. Growth slowed in childhood, with an ultimate height of 147 cm, weight of 43 kg, and head circumference of 53.7 cm all below the third centile. Development was globally delayed. He has never walked alone or spoken meaningful words. He is considered to have severe intellectual disability with a mental age of less than 1 year. Facial manifestations 
include dense eyebrows, long eyelashes, synophrys, upslanted palpebral fissures, left ptosis, strabismus, overhanging columella, short philtrum, wide mouth, high palate, thin lips, and prognathism ( Fig. 2a and b) . The neck is broad, with a low posterior hairline. He had a small ventricular septal defect and patent ductus arteriosus that did not require surgery. The genitalia are hypoplastic. He has short toes, generalized hirsutism, hypotonia, hyperreflexia, seizures, and hearing loss. He has low immunoglobulin A and has experienced unexplained anemia and chronic thrombocytopenia.
During childhood, microcephaly, hypertelorism, and the large open mouth with a tented upper lip dominated the craniofacial phenotype of III.2 (Fig. 2a) . This, combined with severe developmental delay, hypotonia, and hypoplastic genitalia, evoked consideration of alpha thalassemia intellectual disability syndrome as the diagnosis, which was excluded by molecular testing.
III.4 had normal prenatal growth (birth weight 2784 g, length 47 cm, and head circumference 33 cm at 38 weeks). The newborn course was uneventful. Development was globally delayed, but less severe than his older brother. His facial characteristics, genital hypoplasia, and hypotonia were the same as III.2 ( Fig. 2c and d) . He had one febrile seizure. His adult height (152.4 cm) was below the third centile, but his head circumference (57.2 cm) and weight were at the 50th centile. He has severe intellectual disability, with an intelligence quotient of 42. He has hearing loss, a ventricular septal defect, and low immunoglobulin M.
K8435
Abbreviated details are available in the report by Chudley et al. (1999) and updated clinical findings in the three affected males are shown in Table 1 and Fig. 3 . Two major findings in K8435 that had not been reported in the other published families are hypogammaglobulinemia and progressive ataxia after the age of 40 years.
Results

K8905
Genomic DNA from one affected brother was screened for mutations in a panel of 91 XLID genes at the Greenwood Genetic Center. A change, c.203 C > G, was identified in UBE2A. The alteration resulted in a missense mutation, p.P68R, and segregated in the family (Fig. 1) . The alteration was not present in either ExAC or gnomAD databases.
K8435
Exon capture and Sanger sequencing of 718 genes on the X-chromosome was performed as described previously (Tarpey et al., 2009) . A c.328 C > G change was found in the UBE2A gene, which segregated in the family (Fig. 1) .
The change results in a missense mutation, p.Q110E. 
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Discussion
UBE2A plays an important role in the cell's ubiquitination process. This is evident by its high level of conservation during eukaryotic evolution. It interacts with the ligating enzyme, E3 ligase. In general, the process of ubiquitination marks proteins for degradation, a proteasome-mediated process. However, the UBE2A protein does contribute toward the health of a cell in other ways (Haddad et al., 2013) . It has been shown that it controls the clearance of dysfunctional mitochondria and is thus quite instrumental in maintaining the health of a cell's mitochondria. In addition, UBE2A is involved in the post-translational modification process as it assists in the ubiquitination of the histone H2B at lysine 120. H2B K120 marks the portion of the genome that is actively transcribed and then triggers other histone modification pathways, which results in alteration of the chromatin structure.
Only a minority of the 141 genes that cause XLID are associated with syndromes that are readily recognizable on clinical examination (Table 2) . Most XLID syndromes are rare, and because of the low prevalence and the lack of distinctive somatic or neurologic manifestations, elude ready recognition. UBE2A-related XLID, although rare, with only 10 families reported, should be an exception. The craniofacial features alone should be sufficient in most cases for the clinician to suspect the diagnosis and to confirm the same using molecular technologies.
With few exceptions among the 22 affected males reviewed here, prenatal growth was normal (Table 1) . Postnatally, statural growth slowed, with adult height below the third centile in 11/20 (55%). All experienced global developmental delay, with speech acquisition most severely impaired. All except one affected male walked alone, with the age of walking between age 18 months and 6 years. Seizures of variable types and time of onset occurred in most affected males (15/21-71%). In addition to the major manifestations summarized in Table 1 , two affected males had sparse hair, two had epicanthus, two had cataracts, three had short philtrum, two had high or cleft palate, two had preauricular pits or tags, three had short thumbs, one had horseshoe kidney, two had hernias, two had gallstones, two had neonatal hypoglycemia, two had hyperreflexia, and two had recurrent infections.
Very few other syndromes will be confused with UBE2A-related XLID. Waardenburg, Sanfilippo, de Lange, Hajdu-Cheney, and ATR-X syndromes are the most problematic of the single gene disorders and deletion 9q34.3 (Kleefstra syndrome) among the contiguous gene syndromes. In each case, there are distinguishing characteristics and laboratory testing to assist the clinician (Table 3) . It should be noted that in early childhood, the facial phenotype in some patients appears strikingly similar to alpha thalassemia intellectual disability (ATR-X), another XLID syndrome. Other manifestations, particularly the severe developmental impairment, hypoplastic genitalia, and hypotonia, further added to the phenotypic similarity of the two syndromes during childhood.
